InsiderClue
Stocks · Health care · Services-Medical Laboratories

Celcuity Inc.

CELC Clue Score19
United States Fiscal year ends December CIK 0001603454 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

20
Insider
Date
Role
Action
Shares
Price
Amount
Leo Furcht
7 Oct 2026
Director
Exercised, kept
250
$7.60
$1.90K
Baker Bros. Advisors LP
14 Jul 2026
Former 10% owner
Sell indirect
2,838,632
$102.50
$290.96M
Baker Bros. Advisors LP
14 Jul 2026
Former 10% owner
Sell indirect
261,368
$102.50
$26.79M
Lance G. Laing
2 Jun 2026
Chief Science Officer
Exercised, kept
1,000
$9.89
$9.89K
Richard E Buller
4 May 2026
Director
Sold after exercise indirect
365
$143.24
$52.28K
Richard E Buller
4 May 2026
Director
Sold after exercise indirect
2,825
$142.04
$401.25K
Richard E Buller
4 May 2026
Director
Sold after exercise indirect
2,301
$141.03
$324.50K
Richard E Buller
4 May 2026
Director
Sold after exercise indirect
1,670
$139.58
$233.10K
Richard E Buller
4 May 2026
Director
Sold after exercise indirect
550
$139.00
$76.45K
Richard E Buller
4 May 2026
Director
Sold after exercise indirect
1,289
$137.00
$176.59K
David Dalvey
4 May 2026
Director
Sold on a plan indirect
25,000
$140.68
$3.52M
Richard E Buller
31 Mar 2026
Director
Sold after exercise indirect
675
$110.83
$74.81K
Richard E Buller
31 Mar 2026
Director
Sold after exercise indirect
2,325
$110.11
$256.00K
David Dalvey
27 Jan 2026
Director
Sold on a plan indirect
20,000
$120.03
$2.40M
Richard E Buller
5 Dec 2025
Director
Sold after exercise indirect
1,510
$106.04
$160.11K
Richard E Buller
5 Dec 2025
Director
Sold after exercise indirect
1,490
$105.34
$156.96K
Leo Furcht
4 Dec 2025
Director
Exercised, kept
250
$7.60
$1.90K
Richard E Buller
1 Dec 2025
Director
Sold after exercise indirect
1,100
$98.13
$107.95K
David Dalvey
21 Nov 2025
Director
Sold on a plan indirect
15,000
$100.00
$1.50M
Richard E Buller
20 Nov 2025
Director
Sold after exercise indirect
3,900
$96.73
$377.25K

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 180,821
History held since 16 Oct 2017